Abstract

Organoid technology has transformed modern biomedical research by providing powerful human-relevant model systems that recapitulate key aspects of tissue architecture, function, and disease. Over the past decade, organoids have evolved from developmental models into versatile platforms to investigate stem cell behaviour, organogenesis, tissue homeostasis, regeneration, host–microenvironment interactions, and personalised medicine.

Recent advances combining organoids with single-cell and spatial omics, genome engineering, advanced imaging, organ-on-chip technologies, and computational approaches are opening unprecedented opportunities to understand human biology at multiple scales.

The Berlin Organoid Symposium 2026 aims to showcase these breakthroughs by bringing together experts from diverse fields and organ systems. Through scientific exchange between established leaders, young investigators, and technology innovators, the symposium seeks to strengthen the growing organoid community and inspire the next generation of discoveries.

Program

Call for Abstracts: Posters and Selected Talks

Calling all early-career scientists! Join us in shaping the future of the organoid field!

Share your latest organoid research at the Berlin Organoid Symposium and join an inspiring scientific exchange. Selected abstracts will be invited for short oral presentations, and all participants will have the opportunity to present their work during the poster sessions and compete for the Poster Prize.

Whether your work focuses on fundamental organoid biology, disease modelling, regenerative medicine, technology development, or translational applications, we look forward to highlighting the next generation of organoid research.

If you would like to contribute, please indicate this during registration and submit your abstract by the September 25, 2026.

Abstract submission guidelines: Abstracts must be written in English and should not exceed 500 words in total. Submissions should include the following sections: Title, Authors, Affiliations, Introduction, Materials & Methods, Results, Conclusions, and References. A maximum of two references may be included.

Authors are encouraged to present original, unpublished work with clearly stated objectives, methodology, key findings, and conclusions.

Keynote

Nikolaus Rajewsky
Max Delbrück Center / Berlin Institute for Medical Systems Biology (BIMSB), Germany

Kim Bak Jensen
reNEW, Novo Nordisk Foundation Center for Stem Cell Medicine / University of Copenhagen, Denmark

Speakers

Ludovic Vallier
Berlin Institute of Health at Charité & Max Planck Institute for Molecular Genetics, Germany
Stem cells, liver organoids and regenerative medicine

John De Vos
University of Montpellier / INSERM, France

Andreas Hocke
Charité – Universitätsmedizin Berlin, Germany

Gray Camp
Institute of Human Biology, Roche, Basel, Switzerland

Mina Gouti
Max Delbrück Center, Berlin, Germany

Michael Sigal
Charité – Universitätsmedizin Berlin, Germany

Sasha Mendjan
Institute of Molecular Biotechnology (IMBA), Vienna, Austria

Delilah Hendriks
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands

Benedetta Artegiani
Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands

Sina Bartfeld
TU Berlin - Charité – Universitätsmedizin Berlin - Der Simulierte Mensch (Si-M), Germany

Milad Rezvani
Berlin Institute of Health at Charité, Germany

Agnieszka Rybak-Wolf
Max Delbrück Center, Berlin, Germany

Harald Stachelscheid
Berlin Institute of Health at Charité - Core Unit Stem Cells & Organoids (CUSCO), Germany

Mattia F. M. Gerli
University College London, UK

Amanda Andersson-Rolf
Karolinska Institutet, Sweden

Anna Dowbaj
Technische Universität München, Germany

Irene Talon
Berlin Institute of Health at Charité & Max Planck Institute for Molecular Genetics, Germany

Cornelia Schwayer
ETH Zürich, Switzerland, transitioning Max Delbrück Center, Germany

Lukas Ehlen
Berlin Institute of Health at Charité, Germany

Tim Schmäche
Universitätsklinikum Dresden, Germany

Eva-Maria Dehne
TissUse GmbH, Berlin, Germany

Selected short talks will be chosen from submitted abstracts to highlight outstanding contributions from early-career researchers.

Editor Panel Discussion

Anne Doerr (Nature Biotechnology) - Ioanna Pavlaki (Nature Cancer) - Aline Lueckgen (Nature Communications)

Info

When
October 6–7, 2026

Day 1: 8:45 a.m. – 7:00 p.m.
Day 2: 9:00 a.m. – 6:30 p.m.

> Early arrival is appreciated.

Where
Bayer AG – Berlin Campus
Auditorium & Conference Area
Müllerstraße 178
13353 Berlin, Germany

Public transportation: U-Bahn U6 (Reinickendorfer Straße / Wedding),
S-Bahn Ringbahn (S41/S42 Wedding)
Directions
 

Registration (fully booked)
Registration is open until Friday, October 2nd 2026. 

The symposium will welcome researchers from Berlin, Germany and the international organoid community. Due to limited capacity, early registration is recommended.

To support the organisation of this expanded two-day international meeting, supporting the invited speakers from around the world, a change of venue and catering, a registration fee has been introduced for the 2026 edition.

Registration fees

  • €50 – Early-career scientists (students, PhD candidates and postdoctoral researchers)
  • €100 – Advanced scientists (faculty, clinicians and research staff)
  • €200 – Industry professionals

Contact
Organisers of the symposium from the Ludovic Vallier Group:

Anastasiia Maksiuk: anastasiia.maksiuk@bih-charite.de
Dylan Liabeuf: dylan.liabeuf@bih-charite.de
Katja Püstow: katja.puestow@bih-charite.de
Daniella Fradin fradin@molgen.mpg.de